Drug Profile
CNS 1531
Latest Information Update: 06 Dec 1996
Price :
$50
*
At a glance
- Originator CeNeS Pharmaceuticals
- Class Neuroprotectants; Nootropics
- Mechanism of Action Glutamate receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Neurological disorders
Most Recent Events
- 06 Dec 1996 Discontinued-Preclinical for Neurological disorders (Prevention) in USA (Unknown route)